0.0497
0.0000
(0.00%)
At close: January 29 at 3:00:00 PM EST
Breakdown
TTM
6/30/2024
6/30/2023
6/30/2022
6/30/2021
Cash Flows from Used in Operating Activities Direct
-3,568.5660
-3,568.5660
-3,290.0350
-2,436.0480
-3,407.5970
Investing Cash Flow
--
--
--
--
-5.7230
Financing Cash Flow
-22.6230
-22.6230
5,533.0170
-33.1710
-36.9590
End Cash Position
393.1980
393.1980
3,984.3870
1,741.4050
4,210.6240
Interest Paid Supplemental Data
1.0860
1.0860
4.3890
5.0490
1.2610
Capital Expenditure
--
--
--
--
-5.7230
Issuance of Capital Stock
19.8360
19.8360
6,000.7310
--
--
Repurchase of Capital Stock
-275.4270
--
-427.8050
--
--
Free Cash Flow
-3,568.5660
-3,568.5660
-3,290.0350
-2,436.0480
-3,413.3200
6/30/2021 - 3/22/2013
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
PMRA.BE Pharma Mar SA
85.45
+0.41%
7ZA.F Ascelia Pharma AB
0.1790
+3.71%
INNMF Amplia Therapeutics Limited
0.0450
0.00%
22Z.BE Zealand Pharma A/S
97.95
-0.51%
SCPS Scopus BioPharma Inc.
0.0003
0.00%
BIOAF Bioasis Technologies Inc.
0.0002
0.00%
CLABF Core One Labs Inc.
0.0366
-18.67%
KLDO Kaleido Biosciences, Inc.
0.0001
0.00%
WSNAF Wesana Health Holdings Inc.
0.0685
0.00%
BETRF BetterLife Pharma Inc.
0.1140
0.00%